CHAPTER 16Terumo
By Probir Das (Executive Officer of Terumo Corporation, Japan, and Chairman and Managing Director of Asia-Pacific operations)
About Terumo
Terumo is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now its extensive business portfolio ranges from vascular intervention, cardio-surgical solutions, blood transfusion, and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.1
Context
This is an attempt to pen my views on the impact of the COVID-19 pandemic on the medical technology industry. With medical technology being immensely diverse and spanning from a simple gauze dressing or syringe to complex remote robots that perform the intricate intravascular repair of the arteries in the heart or that disinfect hospitals, it is difficult to monolithically describe the pandemic's impact on the industry, and hence I must limit this piece to that constraint of generality. Also, the views expressed here are my own ...
Get The Great Lockdown now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
